vs

Side-by-side financial comparison of BARRETT BUSINESS SERVICES INC (BBSI) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

BARRETT BUSINESS SERVICES INC is the larger business by last-quarter revenue ($321.1M vs $207.3M, roughly 1.5× Ultragenyx Pharmaceutical Inc.). BARRETT BUSINESS SERVICES INC runs the higher net margin — 5.1% vs -62.0%, a 67.1% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs 5.3%). BARRETT BUSINESS SERVICES INC produced more free cash flow last quarter ($70.6M vs $-100.8M). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 9.9%).

Barrett Firearms Manufacturing is an Australian-owned, American manufacturer of firearms and ammunition located in Christiana, Tennessee. It was founded in 1982 by Ronnie G. Barrett for the purpose of building semi-automatic rifles chambered for the .50 BMG ammunition, originally developed for and used in M2 Browning machine guns. Barrett began this work in the early 1980s, and the first working rifles were available in 1982, hence the designation M82. Barrett personally designed every part o...

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

BBSI vs RARE — Head-to-Head

Bigger by revenue
BBSI
BBSI
1.5× larger
BBSI
$321.1M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+20.5% gap
RARE
25.9%
5.3%
BBSI
Higher net margin
BBSI
BBSI
67.1% more per $
BBSI
5.1%
-62.0%
RARE
More free cash flow
BBSI
BBSI
$171.4M more FCF
BBSI
$70.6M
$-100.8M
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
9.9%
BBSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BBSI
BBSI
RARE
RARE
Revenue
$321.1M
$207.3M
Net Profit
$16.4M
$-128.6M
Gross Margin
21.3%
Operating Margin
5.8%
-54.7%
Net Margin
5.1%
-62.0%
Revenue YoY
5.3%
25.9%
Net Profit YoY
-2.4%
3.5%
EPS (diluted)
$0.63
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBSI
BBSI
RARE
RARE
Q4 25
$321.1M
$207.3M
Q3 25
$318.9M
$159.9M
Q2 25
$307.7M
$166.5M
Q1 25
$292.6M
$139.3M
Q4 24
$304.8M
$164.6M
Q3 24
$294.3M
$139.5M
Q2 24
$279.7M
$147.0M
Q1 24
$265.8M
$108.8M
Net Profit
BBSI
BBSI
RARE
RARE
Q4 25
$16.4M
$-128.6M
Q3 25
$20.6M
$-180.4M
Q2 25
$18.5M
$-115.0M
Q1 25
$-1.0M
$-151.1M
Q4 24
$16.8M
$-133.2M
Q3 24
$19.6M
$-133.5M
Q2 24
$16.7M
$-131.6M
Q1 24
$-136.0K
$-170.7M
Gross Margin
BBSI
BBSI
RARE
RARE
Q4 25
21.3%
Q3 25
24.1%
Q2 25
23.8%
Q1 25
14.6%
Q4 24
23.4%
Q3 24
25.3%
Q2 24
24.3%
Q1 24
14.9%
Operating Margin
BBSI
BBSI
RARE
RARE
Q4 25
5.8%
-54.7%
Q3 25
7.8%
-106.9%
Q2 25
7.5%
-64.8%
Q1 25
-1.4%
-102.6%
Q4 24
6.8%
-74.3%
Q3 24
8.0%
-94.6%
Q2 24
7.3%
-79.1%
Q1 24
-1.8%
-151.9%
Net Margin
BBSI
BBSI
RARE
RARE
Q4 25
5.1%
-62.0%
Q3 25
6.5%
-112.8%
Q2 25
6.0%
-69.0%
Q1 25
-0.3%
-108.5%
Q4 24
5.5%
-80.9%
Q3 24
6.7%
-95.7%
Q2 24
6.0%
-89.5%
Q1 24
-0.1%
-156.8%
EPS (diluted)
BBSI
BBSI
RARE
RARE
Q4 25
$0.63
$-1.28
Q3 25
$0.79
$-1.81
Q2 25
$0.70
$-1.17
Q1 25
$-0.04
$-1.57
Q4 24
$0.63
$-1.34
Q3 24
$0.74
$-1.40
Q2 24
$0.62
$-1.52
Q1 24
$-0.01
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBSI
BBSI
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$157.2M
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$241.0M
$-80.0M
Total Assets
$779.1M
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBSI
BBSI
RARE
RARE
Q4 25
$157.2M
$421.0M
Q3 25
$109.8M
$202.5M
Q2 25
$90.4M
$176.3M
Q1 25
$99.1M
$127.1M
Q4 24
$121.9M
$174.0M
Q3 24
$14.4M
$150.6M
Q2 24
$40.3M
$480.7M
Q1 24
$51.3M
$112.3M
Stockholders' Equity
BBSI
BBSI
RARE
RARE
Q4 25
$241.0M
$-80.0M
Q3 25
$240.1M
$9.2M
Q2 25
$225.8M
$151.3M
Q1 25
$213.4M
$144.2M
Q4 24
$221.4M
$255.0M
Q3 24
$215.4M
$346.8M
Q2 24
$199.0M
$432.4M
Q1 24
$189.6M
$140.3M
Total Assets
BBSI
BBSI
RARE
RARE
Q4 25
$779.1M
$1.5B
Q3 25
$777.9M
$1.2B
Q2 25
$713.6M
$1.3B
Q1 25
$778.6M
$1.3B
Q4 24
$745.5M
$1.5B
Q3 24
$725.8M
$1.5B
Q2 24
$688.6M
$1.6B
Q1 24
$747.8M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBSI
BBSI
RARE
RARE
Operating Cash FlowLast quarter
$76.1M
$-99.8M
Free Cash FlowOCF − Capex
$70.6M
$-100.8M
FCF MarginFCF / Revenue
22.0%
-48.6%
Capex IntensityCapex / Revenue
1.7%
0.5%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$47.2M
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBSI
BBSI
RARE
RARE
Q4 25
$76.1M
$-99.8M
Q3 25
$38.4M
$-91.4M
Q2 25
$-53.8M
$-108.3M
Q1 25
$5.2M
$-166.5M
Q4 24
$53.4M
$-79.3M
Q3 24
$-935.0K
$-67.0M
Q2 24
$-51.3M
$-77.0M
Q1 24
$9.0M
$-190.7M
Free Cash Flow
BBSI
BBSI
RARE
RARE
Q4 25
$70.6M
$-100.8M
Q3 25
$34.1M
$-92.7M
Q2 25
$-58.2M
$-110.7M
Q1 25
$697.0K
$-167.8M
Q4 24
$50.2M
$-79.5M
Q3 24
$-4.2M
$-68.6M
Q2 24
$-56.3M
$-79.0M
Q1 24
$6.2M
$-193.9M
FCF Margin
BBSI
BBSI
RARE
RARE
Q4 25
22.0%
-48.6%
Q3 25
10.7%
-58.0%
Q2 25
-18.9%
-66.5%
Q1 25
0.2%
-120.5%
Q4 24
16.5%
-48.3%
Q3 24
-1.4%
-49.2%
Q2 24
-20.1%
-53.7%
Q1 24
2.3%
-178.2%
Capex Intensity
BBSI
BBSI
RARE
RARE
Q4 25
1.7%
0.5%
Q3 25
1.4%
0.8%
Q2 25
1.4%
1.5%
Q1 25
1.5%
1.0%
Q4 24
1.0%
0.1%
Q3 24
1.1%
1.2%
Q2 24
1.8%
1.4%
Q1 24
1.0%
3.0%
Cash Conversion
BBSI
BBSI
RARE
RARE
Q4 25
4.64×
Q3 25
1.86×
Q2 25
-2.92×
Q1 25
Q4 24
3.18×
Q3 24
-0.05×
Q2 24
-3.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BBSI
BBSI

Professional Employer Services$303.6M95%
Staffing Services$17.6M5%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons